1. Home
  2. NWBI vs SRPT Comparison

NWBI vs SRPT Comparison

Compare NWBI & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWBI
  • SRPT
  • Stock Information
  • Founded
  • NWBI 1896
  • SRPT 1980
  • Country
  • NWBI United States
  • SRPT United States
  • Employees
  • NWBI N/A
  • SRPT N/A
  • Industry
  • NWBI Major Banks
  • SRPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWBI Finance
  • SRPT Health Care
  • Exchange
  • NWBI Nasdaq
  • SRPT Nasdaq
  • Market Cap
  • NWBI 1.8B
  • SRPT 1.9B
  • IPO Year
  • NWBI N/A
  • SRPT 1997
  • Fundamental
  • Price
  • NWBI $11.99
  • SRPT $18.67
  • Analyst Decision
  • NWBI Buy
  • SRPT Hold
  • Analyst Count
  • NWBI 2
  • SRPT 30
  • Target Price
  • NWBI $15.00
  • SRPT $35.93
  • AVG Volume (30 Days)
  • NWBI 898.9K
  • SRPT 6.0M
  • Earning Date
  • NWBI 10-27-2025
  • SRPT 11-03-2025
  • Dividend Yield
  • NWBI 6.67%
  • SRPT N/A
  • EPS Growth
  • NWBI 14.20
  • SRPT N/A
  • EPS
  • NWBI 0.87
  • SRPT N/A
  • Revenue
  • NWBI $564,562,000.00
  • SRPT $2,413,715,000.00
  • Revenue This Year
  • NWBI $7.26
  • SRPT $10.20
  • Revenue Next Year
  • NWBI $13.90
  • SRPT N/A
  • P/E Ratio
  • NWBI $13.83
  • SRPT N/A
  • Revenue Growth
  • NWBI 15.71
  • SRPT 47.15
  • 52 Week Low
  • NWBI $10.75
  • SRPT $10.42
  • 52 Week High
  • NWBI $15.42
  • SRPT $138.81
  • Technical
  • Relative Strength Index (RSI)
  • NWBI 45.88
  • SRPT 41.13
  • Support Level
  • NWBI $11.54
  • SRPT $15.08
  • Resistance Level
  • NWBI $11.86
  • SRPT $24.55
  • Average True Range (ATR)
  • NWBI 0.25
  • SRPT 1.34
  • MACD
  • NWBI -0.04
  • SRPT -0.65
  • Stochastic Oscillator
  • NWBI 41.86
  • SRPT 37.91

About NWBI Northwest Bancshares Inc.

Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: